Clinical Trial Update: CEQUA for Sjogren's Syndrome Dry Eye [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for CEQUA in Sjogren's syndrome–associated dry eye has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Sjögren Syndrome

Drugs mentioned

• Cequa (cyclosporine ophthalmic solution)

Snippet

Sponsor: Center for Ophthalmic and Vision Research, LLC | Conditions: Dry Eye, Dry Eye Syndromes | Phase 4 | Status: COMPLETED